-
1دورية أكاديمية
المؤلفون: Chiawpanit C; Cell Engineering for Cancer Therapy Research Group, Chiang Mai University, Chiang Mai, Thailand; Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand; Office of Research Administration, Chiang Mai University, Chiang Mai, Thailand., Wathikthinnakorn M; Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Sawasdee N; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Research Department, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Phanthaphol N; College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom., Sujjitjoon J; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Research Department, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Junking M; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Research Department, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Yamabhai M; Molecular Biotechnology Laboratory, School of Biotechnology, Institute of Agriculture Technology, Suranaree University of Technology, Nakhon Ratchasima, Thailand., Panaampon J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Yenchitsomanus PT; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Research Department, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Panya A; Cell Engineering for Cancer Therapy Research Group, Chiang Mai University, Chiang Mai, Thailand; Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand. Electronic address: aussara.pan@cmu.ac.th.
المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Jul 30; Vol. 136, pp. 112273. Date of Electronic Publication: 2024 May 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
مواضيع طبية MeSH: Single-Chain Antibodies*/genetics , Single-Chain Antibodies*/therapeutic use , Single-Chain Antibodies*/immunology , Cholangiocarcinoma*/therapy , Cholangiocarcinoma*/immunology , Receptors, Chimeric Antigen*/immunology , Receptors, Chimeric Antigen*/genetics , Receptors, Chimeric Antigen*/metabolism , Killer Cells, Natural*/immunology , Bile Duct Neoplasms*/therapy , Bile Duct Neoplasms*/immunology , Proto-Oncogene Proteins c-met*/metabolism , Proto-Oncogene Proteins c-met*/immunology, Humans ; Cell Line, Tumor ; Immunotherapy, Adoptive/methods ; Immunotherapy/methods ; Precision Medicine
-
2دورية أكاديمية
المؤلفون: Hughes AD; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Teachey DT; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Diorio C; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. diorioc@chop.edu.; Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. diorioc@chop.edu.
المصدر: Seminars in immunopathology [Semin Immunopathol] 2024 Jul 16; Vol. 46 (3-4), pp. 5. Date of Electronic Publication: 2024 Jul 16.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 101308769 Publication Model: Electronic Cited Medium: Internet ISSN: 1863-2300 (Electronic) Linking ISSN: 18632297 NLM ISO Abbreviation: Semin Immunopathol Subsets: MEDLINE
مواضيع طبية MeSH: Immunotherapy, Adoptive*/adverse effects , Immunotherapy, Adoptive*/methods , Cytokine Release Syndrome*/etiology , Cytokine Release Syndrome*/therapy , Receptors, Chimeric Antigen*/metabolism , Receptors, Chimeric Antigen*/immunology , Receptors, Chimeric Antigen*/genetics , Neoplasms*/therapy , Neoplasms*/immunology , Neoplasms*/etiology , Cytokines*/metabolism, Humans ; Animals ; Neurotoxicity Syndromes/etiology ; Neurotoxicity Syndromes/therapy ; Disease Management ; Lymphohistiocytosis, Hemophagocytic/therapy ; Lymphohistiocytosis, Hemophagocytic/etiology ; Lymphohistiocytosis, Hemophagocytic/immunology ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism
-
3دورية أكاديمية
المؤلفون: Ma R; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA; William T. Shearer Center for Human Immunobiology, Texas Children's Hospital, Houston, TX 77030, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Woods M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Burkhardt P; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Crooks N; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., van Leeuwen DG; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Shmidt D; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Couturier J; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Chaumette A; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Popat D; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Hill LC; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Rouce RH; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Thakkar S; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Orozco AF; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA., Carisey AF; William T. Shearer Center for Human Immunobiology, Texas Children's Hospital, Houston, TX 77030, USA., Brenner MK; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Mamonkin M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: mamonkin@bcm.edu.
المصدر: Cell reports. Medicine [Cell Rep Med] 2024 Jul 16; Vol. 5 (7), pp. 101628. Date of Electronic Publication: 2024 Jul 09.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE
مواضيع طبية MeSH: CD5 Antigens*/metabolism , Receptors, Chimeric Antigen*/metabolism , Receptors, Chimeric Antigen*/immunology, Humans ; Cytotoxicity, Immunologic ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Immunotherapy, Adoptive/methods ; Animals ; Receptors, Antigen, T-Cell/metabolism ; Receptors, Antigen, T-Cell/immunology
-
4دورية أكاديمية
المؤلفون: Deng T; Department of Research and Development, Hrain Biotechnology Co., Ltd., 1238 Zhangjiang Road, Pudong New District, Shanghai, China., Deng Y; Department of Research and Development, Hrain Biotechnology Co., Ltd., 1238 Zhangjiang Road, Pudong New District, Shanghai, China., Tsao ST; Department of Research and Development, Hrain Biotechnology Co., Ltd., 1238 Zhangjiang Road, Pudong New District, Shanghai, China., Xiong Q; Department of Research and Development, Hrain Biotechnology Co., Ltd., 1238 Zhangjiang Road, Pudong New District, Shanghai, China., Yao Y; Department of Research and Development, Hrain Biotechnology Co., Ltd., 1238 Zhangjiang Road, Pudong New District, Shanghai, China., Liu C; Regulatory Affairs Department, Hrain Biotechnology Co., Ltd., 1238 Zhangjiang Road, Pudong New District, Shanghai, China., Gu MY; Department of Research and Development, Hrain Biotechnology Co., Ltd., 1238 Zhangjiang Road, Pudong New District, Shanghai, China., Huang F; Department of Research and Development, Hrain Biotechnology Co., Ltd., 1238 Zhangjiang Road, Pudong New District, Shanghai, China. huangfei@dashengbio.com., Wang H; Department of Research and Development, Hrain Biotechnology Co., Ltd., 1238 Zhangjiang Road, Pudong New District, Shanghai, China. wanghaiying@dashengbio.com.
المصدر: Journal of translational medicine [J Transl Med] 2024 Jul 08; Vol. 22 (1), pp. 633. Date of Electronic Publication: 2024 Jul 08.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
مواضيع طبية MeSH: Pancreatic Neoplasms*/therapy , Pancreatic Neoplasms*/immunology , Pancreatic Neoplasms*/pathology , Receptors, Chimeric Antigen*/metabolism , Receptors, Chimeric Antigen*/immunology , Immunotherapy, Adoptive*/methods , B7 Antigens*/metabolism , B7 Antigens*/immunology, Humans ; Animals ; Cell Line, Tumor ; Xenograft Model Antitumor Assays ; Mice ; Cell Proliferation ; T-Lymphocytes/immunology
-
5دورية أكاديمية
المؤلفون: Hull CM; Leucid Bio Ltd, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Larcombe-Young D; King's College London, School of Cancer and Pharmaceutical Sciences, CAR Mechanics Lab, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Mazza R; Leucid Bio Ltd, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., George M; King's College London, Department of Infectious Diseases, School of Immunology and Microbial Sciences, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Davies DM; Leucid Bio Ltd, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Schurich A; King's College London, Department of Infectious Diseases, School of Immunology and Microbial Sciences, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Maher J; Leucid Bio Ltd, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK; King's College London, School of Cancer and Pharmaceutical Sciences, CAR Mechanics Lab, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK; Department of Immunology, Eastbourne Hospital, Kings Drive, Eastbourne, East Sussex BN21 2UD, UK. Electronic address: john.maher@kcl.ac.uk.
المصدر: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Jul 03; Vol. 32 (7), pp. 2373-2392. Date of Electronic Publication: 2024 May 14.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE
مواضيع طبية MeSH: Interleukin-18*/metabolism , Granzymes*/metabolism , Immunotherapy, Adoptive*/methods , Receptors, Chimeric Antigen*/metabolism , Receptors, Chimeric Antigen*/immunology, Animals ; Mice ; Humans ; Cell Line, Tumor ; Tumor Microenvironment/immunology ; Receptors, Antigen, T-Cell, gamma-delta/metabolism ; Receptors, Antigen, T-Cell, gamma-delta/immunology ; Neoplasms/therapy ; Neoplasms/immunology ; Neoplasms/metabolism ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Lymphocyte Activation/immunology ; Cytotoxicity, Immunologic ; Xenograft Model Antitumor Assays ; Interferon-gamma/metabolism
-
6دورية أكاديمية
المؤلفون: Chupradit K; Siriraj Center for Regenerative Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Muneekaew S; Siriraj Center for Regenerative Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Wattanapanitch M; Siriraj Center for Regenerative Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. methichit.wat@mahidol.ac.th.
المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Jul 02; Vol. 73 (9), pp. 170. Date of Electronic Publication: 2024 Jul 02.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
مواضيع طبية MeSH: Phagocytosis*/immunology , Receptors, Chimeric Antigen*/immunology , Receptors, Chimeric Antigen*/genetics , Receptors, Chimeric Antigen*/metabolism , Macrophages*/immunology , Macrophages*/metabolism , Immunotherapy, Adoptive*/methods , Basigin*/immunology , Basigin*/metabolism, Humans ; Neoplasms/immunology ; Neoplasms/therapy ; Mice ; Animals ; Cell Line, Tumor ; Tumor Microenvironment/immunology
-
7دورية أكاديمية
المؤلفون: Moraly J; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Université Sorbonne Paris Cité, Paris, France., Kondo T; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Benzaoui M; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Université de Montpellier, Institut de Génétique Moléculaire de Montpellier, CNRS, Montpellier, France., DuSold J; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Talluri S; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Pouzolles MC; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Chien C; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Dardalhon V; Université de Montpellier, Institut de Génétique Moléculaire de Montpellier, CNRS, Montpellier, France., Taylor N; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Université de Montpellier, Institut de Génétique Moléculaire de Montpellier, CNRS, Montpellier, France.
المصدر: Molecular oncology [Mol Oncol] 2024 Jul; Vol. 18 (7), pp. 1695-1718. Date of Electronic Publication: 2024 Jun 22.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Tumor Microenvironment*/immunology , Receptors, Chimeric Antigen*/metabolism , Receptors, Chimeric Antigen*/immunology, Humans ; Animals ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Neoplasms/immunology ; Neoplasms/therapy ; Neoplasms/metabolism ; Neoplasms/pathology ; Immunotherapy, Adoptive/methods
-
8دورية أكاديمية
المؤلفون: Żyłka K; The Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland., Kubicki T; The Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland.; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Gil L; The Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland., Dytfeld D; The Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland.
المصدر: Expert review of hematology [Expert Rev Hematol] 2024 Jul; Vol. 17 (7), pp. 295-312. Date of Electronic Publication: 2024 Jun 26.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE
مواضيع طبية MeSH: Multiple Myeloma*/therapy , Multiple Myeloma*/immunology , T-Lymphocytes*/immunology , T-Lymphocytes*/metabolism , Receptors, Chimeric Antigen*/metabolism , Receptors, Chimeric Antigen*/immunology , Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/adverse effects , Antibodies, Bispecific*/therapeutic use, Humans ; T-Cell Exhaustion
-
9دورية أكاديمية
المؤلفون: Zhang Q; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Zhu X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. zhuxiaojian@hust.edu.cn., Xiao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. yixiao@tjh.tjmu.edu.cn.
المصدر: Annals of hematology [Ann Hematol] 2024 Jul; Vol. 103 (7), pp. 2197-2206. Date of Electronic Publication: 2024 Feb 08.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
مواضيع طبية MeSH: Immunotherapy, Adoptive*/adverse effects , Immunotherapy, Adoptive*/methods , Cytokine Release Syndrome*/etiology , Cytokine Release Syndrome*/therapy , Endothelial Cells*/metabolism , Endothelial Cells*/immunology , Receptors, Chimeric Antigen*/immunology , Receptors, Chimeric Antigen*/therapeutic use , Neurotoxicity Syndromes*/etiology, Humans ; Hematologic Neoplasms/therapy
-
10دورية أكاديمية
المؤلفون: Song HW; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Prochazkova M; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Shao L; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Traynor R; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Underwood S; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Black M; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Fellowes V; Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Shi R; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Pouzolles M; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Chou HC; Genomics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Cheuk AT; Genomics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Taylor N; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Jin P; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Somerville RP; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Stroncek DF; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Khan J; Genomics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Highfill SL; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA. Electronic address: steven.highfill@nih.gov.
المصدر: Cytotherapy [Cytotherapy] 2024 Jul; Vol. 26 (7), pp. 757-768. Date of Electronic Publication: 2024 Mar 12.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE
مواضيع طبية MeSH: Cell Differentiation* , Immunotherapy, Adoptive*/methods , Receptors, Chimeric Antigen*/genetics , Receptors, Chimeric Antigen*/metabolism, Humans ; Cell Proliferation ; T-Lymphocytes/metabolism ; T-Lymphocytes/cytology ; Bioreactors ; Cell Culture Techniques/methods ; CD8-Positive T-Lymphocytes/immunology